1. Home
  2. IRWD vs NIE Comparison

IRWD vs NIE Comparison

Compare IRWD & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.14

Market Cap

741.8M

Sector

Health Care

ML Signal

HOLD

Logo Virtus Equity & Convertible Income Fund of Beneficial Interest

NIE

Virtus Equity & Convertible Income Fund of Beneficial Interest

HOLD

Current Price

$23.38

Market Cap

704.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRWD
NIE
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
741.8M
704.1M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
IRWD
NIE
Price
$3.14
$23.38
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$4.94
N/A
AVG Volume (30 Days)
2.9M
50.9K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
9.04%
EPS Growth
1400.00
N/A
EPS
0.15
N/A
Revenue
$298,276,000.00
N/A
Revenue This Year
$57.95
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$21.27
N/A
Revenue Growth
8.88
N/A
52 Week Low
$0.55
$18.54
52 Week High
$5.78
$26.00

Technical Indicators

Market Signals
Indicator
IRWD
NIE
Relative Strength Index (RSI) 39.93 28.54
Support Level $3.08 $22.74
Resistance Level $3.53 $25.62
Average True Range (ATR) 0.22 0.36
MACD 0.01 -0.10
Stochastic Oscillator 16.85 10.64

Price Performance

Historical Comparison
IRWD
NIE

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest

Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.

Share on Social Networks: